CIPRIANO JOHN 4
4 · CEL SCI CORP · Filed Nov 29, 2021
Insider Transaction Report
Form 4
CEL SCI CORPCVM
CIPRIANO JOHN
Senior Vice President
Transactions
- Award
Options
2021-11-19$0.01/sh+50,000$500→ 788,827 totalExercise: $10.48Exp: 2031-11-18→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.48 per share. The stock options vest 100% upon the approval of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia. None of the options will be exercisable before November 19, 2022.